CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity.
- Resource Type
- Article
- Source
- Cell Discovery; 11/8/2022, Vol. 8 Issue 1, p1-16, 16p
- Subject
SARS-CoV-2 PEPTIDES TOLL-like receptors AVIAN influenza T cells COVID-19 vaccines - Language
- ISSN
- 20565968